title: [Opinion. The German Ophthalmological Society,the Retina Society and the Professional Association of German Ophthalmologists. Treatment of diabetic maculopathy].
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D003930:Diabetic Retinopathy / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D057586:Vitreoretinal Surgery / Q000379:methods*
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A